| Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
 |
World Community Grid Forums
Category: Active Research
Forum: Mapping Cancer Markers Forum
Thread: The Cancer Daily News : Stay connected to the latest news |
| No member browsing this thread |
|
Thread Status: Active Total posts in this thread: 178
|
|
| Author |
|
|
[CSF] Thomas Dupont
Veteran Cruncher Joined: Aug 25, 2013 Post Count: 685 Status: Offline |
CANCER du SEIN : L’Herceptine aura révolutionné son traitement
----------------------------------------"Ce n’est plus un scoop, mais ces résultats d’une étude de suivi de plus de 8 ans, viennent confirmer le bénéfice de survie de l’ajout d’Herceptine (trastuzumab) à la chimiothérapie dans le traitement du cancer du sein HER2-positif de stade précoce. Une amélioration considérable, aujourd’hui estimée à 37% pour la survie et à 40% de réduction du risque de récidive, vs chimiothérapie seule. Ces toute dernières données, publiées dans le Journal of Clinical Oncology, montrent à quel point l’arrivée du trastuzumab a modifié « le cours de l’histoire » de ce cancer du sein." http://www.santelog.com/news/cancerologie/can...relasuite.htm#lirelasuite BREAST CANCER : The Herceptin has revolutionized his treatment. "This is not a scoop, but the results of a follow-up study of more than 8 years, confirm the survival benefit of adding Herceptin (trastuzumab) to chemotherapy in the treatment of breast cancer HER2 -positive early stage. A considerable improvement, now estimated at 37% for survival and a 40% reduction in risk of recurrence, versus chemotherapy alone. All these recent data, published in the Journal of Clinical Oncology, show how the advent of trastuzumab has changed "the course of history" of the breast cancer." http://www.santelog.com/news/cancerologie/can...relasuite.htm#lirelasuite French Article http://www.santelog.com/news/cancerologie/can...relasuite.htm#lirelasuite |
||
|
|
[CSF] Thomas Dupont
Veteran Cruncher Joined: Aug 25, 2013 Post Count: 685 Status: Offline |
1- Detecting cancer earlier is goal of new medical imaging technology
----------------------------------------"A new medical imaging method could help physicians detect cancer and other diseases earlier than before, speeding treatment and reducing the need for invasive, time-consuming biopsies. The potentially lifesaving technique uses nanotechnology and shortwave infrared light to reveal small cancerous tumors and cardiovascular lesions deep inside the body." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 2- New analysis methodology may revolutionize breast cancer therapy "Stroma cells are derived from connective tissue and may critically influence tumor growth. This knowledge is not new. However, a team of researchers has developed a novel methodology for investigation. Using modern mass spectrometry, tumor-promoting activities from breast fibroblasts were directly determined from needle biopsy samples." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 3- 'Designer' nanodevice could improve treatment options for cancer sufferers "Cancer diagnostics and treatment options could be drastically improved with the creation of a ‘designer’ nanodevice currently being developed by an international team of researchers. The diagnostic 'nanodecoder', which will consist of self-assembled DNA and protein nanostructures, will greatly advance biomarker detection and provide accurate molecular characterization enabling more detailed evaluation of how diseased tissues respond to therapies, they say." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 4- How radiotherapy kills cancer cells "A new discovery in experimental physics has implications for understanding how radiotherapy kills cancer cells, among other things." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 |
||
|
|
[CSF] Thomas Dupont
Veteran Cruncher Joined: Aug 25, 2013 Post Count: 685 Status: Offline |
CANCER du POUMON : Une nouvelle étape vers un test sanguin
----------------------------------------"Test de l’haleine ou tests sanguins, nombreuses sont les recherches de développement d’un test de « diagnostic » simple et peu coûteux permettant une première approche de détection du cancer du poumon, sans passer par la succession de tests de radiographie, au scanner et à la biopsie. Cette étude présentée au Congrès CHEST 2014 (Austin) montre que les patients atteints de cancer du poumon non à petites cellules (CPNPC) de stade I au stade III présentent des profils de métabolites différents dans leur sang que les patients à risque, mais sans cancer du poumon." http://www.santelog.com/news/cancerologie/can...relasuite.htm#lirelasuite Blood biomarker may detect lung cancer "A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 http://www.eurekalert.org/pub_releases/2014-10/acoc-bbm102114.php |
||
|
|
[CSF] Thomas Dupont
Veteran Cruncher Joined: Aug 25, 2013 Post Count: 685 Status: Offline |
1- Finally: Missing link between vitamin D, prostate cancer
----------------------------------------"A new study offers compelling evidence that inflammation may be the link between vitamin D and prostate cancer. Specifically, the study shows that the gene GDF-15, known to be upregulated by vitamin D, is notably absent in samples of human prostate cancer driven by inflammation." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 2- Highly effective new anti-cancer drug shows few side effects in mice "A new drug, OTS964, can eradicate aggressive human lung cancers transplanted into mice, scientists report. It inhibits the action of a protein that is overproduced by several tumor types but is rarely expressed in healthy adult tissues. Without it, cancer cells fail to complete the cell-division process and die." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 3- Fast modeling of cancer mutations "A new genome-editing technique enables rapid analysis of genes mutated in tumors, researchers report. Sequencing the genomes of tumor cells has revealed thousands of genetic mutations linked with cancer. However, sifting through this deluge of information to figure out which of these mutations actually drive cancer growth has proven to be a tedious, time-consuming process -- until now." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 4- Quality of biopsy directly linked to survival in patients with bladder cancer "The quality of diagnostic staging using biopsy in patients with bladder cancer is directly linked with survival, meaning those that don’t get optimal biopsies are more likely to die from their disease, researchers have shown for the first time." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 5- Silencing the speech gene FOXP2 causes breast cancer cells to metastasize "It is an intricate network of activity that enables breast cancer cells to move from the primary breast tumor and set up new growths in other parts of the body, a process known as metastasis. Researchers have now discovered an unexpected link between a transcription factor known to regulate speech and language development and metastatic colonization of breast cancer." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 6- Early palliative care can cut hospital readmissions for cancer patients "A new collaborative model in cancer care has reduced the rates at which patients were sent to intensive care or readmitted to the hospital after discharge. In the new treatment model, medical oncologists and palliative care physicians partnered in a "co-rounding" format to deliver cancer care for patients admitted to a solid tumor unit. The model fostered collaboration and communication between the specialists, who met several times a day to discuss patient care." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 7- Hidden subpopulation of melanoma cells discovered "A subpopulation of melanoma cancer cells has been discovered in the blood vessels of tumors, researchers report. These cells, which mimic non-cancerous endothelial cells that normally populate blood vessels, could provide researchers with another target for cancer therapies." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 |
||
|
|
[CSF] Thomas Dupont
Veteran Cruncher Joined: Aug 25, 2013 Post Count: 685 Status: Offline |
1- Novel software application can stratify early-stage non-small cell lung cancer patients
----------------------------------------"Computer-Aided Nodule Assessment and Risk Yield, is a novel software tool that can automatically quantitate adenocarcinoma pulmonary nodule characteristics from non-invasive high resolution computed tomography images and stratify non-small cell lung cancer patients into risk groups that have significantly different disease-free survival outcome." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 2- Cancer exosome 'micro factories' aid in cancer progression "Exosomes, tiny, virus-sized particles released by cancer cells, can bioengineer micro-RNA molecules resulting in tumor growth. They do so with the help of proteins, such as one named Dicer, scientists have discovered." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 3- YEATS protein potential therapeutic target for cancer "Federal Express and UPS are no match for the human body when it comes to distribution. There exists in cancer biology an impressive packaging and delivery system that influences whether your body will develop cancer or not, scientists say. Researchers have announced findings indicating a possible new way of manipulating chromatin and its histones through a protein reader known as the YEATS domain protein, providing new hope for cancer treatment." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 4- Experimental breast cancer drug holds promise in combination therapy for Ewing sarcoma "Ewing sarcoma tumors disappeared and did not return in more than 70 percent of mice treated with combination therapy that included drugs from a family of experimental agents developed to fight breast cancer, report researchers." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 5- Thyroid cancer genome analysis finds markers of aggressive tumors "A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 6- Cancer patients should not hesitate to speak with their doctors about dietary supplements "Many cancer patients use dietary supplements such as vitamins, minerals and herbs or other botanicals but often don't tell their doctor. This gap in communication can happen when patients believe that their doctors are indifferent or negative toward their use of these supplements. As a result, patients may find information about dietary supplements from unreliable sources, exposing themselves to unneeded risks, experts say." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 7- Powerful new class of weapons found in the war on cancer "Small molecules that can represent a new class of anticancer drugs with a novel target for the treatment of lung cancer have been identified by an interdisciplinary team of researchers. "These compounds hold potential as an entirely new class of anticancer drugs with a unique therapeutic target for the treatment of cancers," one expert noted." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 8- Two-color barcodes: Dynamic duo to fight crime, cancer "Miniature two-color barcodes have the potential to combat forgery and track cancerous cells, investigators say. Tiny rod-like single crystals that act as miniature dual-color barcodes have been synthesized by researchers. The researchers have demonstrated the potential of these barcodes for two very different applications: anti-counterfeiting measures and cell tracking." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 9- Readmission after colorectal cancer surgery as quality measure "No significant variation was found in hospital readmission rates after colorectal cancer surgery when the data was adjusted to account for patient characteristics, coexisting illnesses and operation types, which may prompt questions about the use of readmission rates as a measure of hospital quality." http://www.sciencedaily.com/releases/2014/10/...ily%3A+Top+Health+News%29 |
||
|
|
[CSF] Thomas Dupont
Veteran Cruncher Joined: Aug 25, 2013 Post Count: 685 Status: Offline |
Popularity Survey
----------------------------------------You regularly read this thread ? You want that it continues to exist ? If so, thanks to respond to this post with a +1, +2, +3 etc... The continuity of this thread will depend on its popularity. Thank you all for your participation  |
||
|
|
l_mckeon
Senior Cruncher Joined: Oct 20, 2007 Post Count: 439 Status: Offline Project Badges: 
|
Yes, I read it every new post, and check out most of the links.
But we don't need "no news today" messages, unless you're going away for a while on holidays, for example. |
||
|
|
[VENETO] boboviz
Senior Cruncher Joined: Aug 17, 2008 Post Count: 183 Status: Offline Project Badges: 
|
Popularity Survey You regularly read this thread ? You want that it continues to exist ? +2 |
||
|
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
+5 :D
|
||
|
|
Barnsley_Tatts
Senior Cruncher Joined: Nov 3, 2005 Post Count: 283 Status: Offline Project Badges: 
|
----------------------------------------  |
||
|
|
|